GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:002241112 | Liver | HCC | cellular component disassembly | 282/7958 | 443/18723 | 1.02e-19 | 1.38e-17 | 282 |
GO:190300811 | Liver | HCC | organelle disassembly | 89/7958 | 114/18723 | 8.68e-15 | 5.73e-13 | 89 |
GO:01400531 | Liver | HCC | mitochondrial gene expression | 82/7958 | 108/18723 | 1.49e-12 | 7.20e-11 | 82 |
GO:00325431 | Liver | HCC | mitochondrial translation | 62/7958 | 76/18723 | 2.95e-12 | 1.34e-10 | 62 |
GO:003298411 | Liver | HCC | protein-containing complex disassembly | 138/7958 | 224/18723 | 5.59e-09 | 1.46e-07 | 138 |
GO:00436242 | Liver | HCC | cellular protein complex disassembly | 71/7958 | 136/18723 | 1.39e-02 | 4.95e-02 | 71 |
GO:002241119 | Oral cavity | OSCC | cellular component disassembly | 283/7305 | 443/18723 | 9.57e-27 | 3.37e-24 | 283 |
GO:19030088 | Oral cavity | OSCC | organelle disassembly | 85/7305 | 114/18723 | 1.15e-14 | 6.93e-13 | 85 |
GO:01400533 | Oral cavity | OSCC | mitochondrial gene expression | 78/7305 | 108/18723 | 2.37e-12 | 9.86e-11 | 78 |
GO:00325434 | Oral cavity | OSCC | mitochondrial translation | 59/7305 | 76/18723 | 7.21e-12 | 2.70e-10 | 59 |
GO:003298410 | Oral cavity | OSCC | protein-containing complex disassembly | 136/7305 | 224/18723 | 3.42e-11 | 1.13e-09 | 136 |
GO:0006415 | Oral cavity | OSCC | translational termination | 13/7305 | 18/18723 | 4.45e-03 | 1.79e-02 | 13 |
GO:00436244 | Oral cavity | OSCC | cellular protein complex disassembly | 68/7305 | 136/18723 | 5.84e-03 | 2.24e-02 | 68 |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
GFM2 | SNV | Missense_Mutation | | c.1561G>A | p.Val521Met | p.V521M | Q969S9 | protein_coding | deleterious(0) | possibly_damaging(0.714) | TCGA-B5-A11Y-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
GFM2 | SNV | Missense_Mutation | novel | c.2030C>T | p.Ala677Val | p.A677V | Q969S9 | protein_coding | tolerated(0.44) | benign(0.053) | TCGA-B5-A3FA-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
GFM2 | SNV | Missense_Mutation | rs780130081 | c.1187A>G | p.Gln396Arg | p.Q396R | Q969S9 | protein_coding | tolerated(0.15) | benign(0.115) | TCGA-B5-A3FA-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
GFM2 | SNV | Missense_Mutation | rs367960522 | c.2020N>A | p.Val674Met | p.V674M | Q969S9 | protein_coding | tolerated(0.64) | benign(0.097) | TCGA-B5-A3FC-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
GFM2 | SNV | Missense_Mutation | rs756501893 | c.1717N>T | p.Arg573Cys | p.R573C | Q969S9 | protein_coding | tolerated(0.06) | benign(0.022) | TCGA-B5-A3FC-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
GFM2 | SNV | Missense_Mutation | novel | c.1031N>A | p.Ala344Asp | p.A344D | Q969S9 | protein_coding | deleterious(0) | probably_damaging(0.991) | TCGA-B5-A3FC-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
GFM2 | SNV | Missense_Mutation | novel | c.2264T>C | p.Leu755Ser | p.L755S | Q969S9 | protein_coding | deleterious(0.02) | probably_damaging(0.942) | TCGA-D1-A175-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Chemotherapy | paclitaxel | SD |
GFM2 | SNV | Missense_Mutation | novel | c.639N>T | p.Glu213Asp | p.E213D | Q969S9 | protein_coding | tolerated(0.24) | benign(0.02) | TCGA-E6-A1LX-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
GFM2 | SNV | Missense_Mutation | novel | c.391G>T | p.Asp131Tyr | p.D131Y | Q969S9 | protein_coding | tolerated(0.15) | benign(0.115) | TCGA-E6-A1M0-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | carboplatin | SD |
GFM2 | SNV | Missense_Mutation | rs756501893 | c.1717N>T | p.Arg573Cys | p.R573C | Q969S9 | protein_coding | tolerated(0.06) | benign(0.022) | TCGA-EY-A1G8-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |